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Abstract
IMPORTANCE—National guidelines do not agree on the role of carotid screening in 
asymptomatic patients (ie, patients who have not had a stroke or transient ischemic attack). 
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Recently, several physician organizations participating in the Choosing Wisely campaign have 
identified carotid imaging in selected asymptomatic populations as being of low value. However, 
the majority of patients who are evaluated for carotid stenosis and subsequently revascularized are 
asymptomatic.
OBJECTIVE—To better understand why asymptomatic patients who undergo revascularization 
receive initial carotid imaging.
DESIGN, SETTING, AND PARTICIPANTS—Retrospective cohort study of 4127 Veterans 
Health Administration patients 65 years and older undergoing carotid revascularization for 
asymptomatic carotid stenosis between 2005 and 2009.
MAIN OUTCOMES AND MEASURES—Indications for carotid ultrasounds were extracted 
using trained abstractors. Frequency of indications and appropriateness of initial carotid ultrasound 
imaging for patients within each rating category after the intervention were reported.
RESULTS—The mean (SD) age of this cohort of 4127 patients was 73.6 (5.9) years; 4014 
(98.8%) were male. Overall, there were 5226 indications for 4063 carotid ultrasounds. The most 
common indications listed were carotid bruit (1578 [30.2% of indications]) and follow-up for 
carotid disease (stenosis/history of carotid disease) in patients who had previously documented 
carotid stenosis (1087 [20.8% of indications]). Multiple vascular risk factors were the next most 
common indication listed. Rates of appropriate, uncertain, and inappropriate imaging were 5.4% 
(227 indications), 83.4% (3387 indications), and 11.3% (458 indications), respectively. Among the 
most common inappropriate indications were dizziness/vertigo and syncope. Among the 4063 
patients, 3373 (83.0%) received a carotid endarterectomy. Overall, 663 procedures were performed 
in patients 80 years and older.
CONCLUSIONS AND RELEVANCE—Carotid bruit and follow-up for carotid disease 
accounted for approximately half of all indications provided by physicians for carotid testing. 
Strong consideration should be given to improving the evidence base around carotid testing, 
especially around monitoring stenosis over long periods and evaluating carotid bruits. Targeting 
carotid ultrasound ordering with decision support tools may also be an important step in reducing 
use of low-value imaging.
Stroke is the fifth most common cause of death and is a major cause of disability among US 
adults.1 Approximately 10% to 15% of ischemic strokes are attributable to atherosclerosis of 
the carotid arteries.2 Secondary stroke prevention guidelines support the use of carotid 
imaging to evaluate patients with a recent cerebrovascular event to assess them for carotid 
plaque.3 However, national guidelines conflict on the role of carotid screening in 
asymptomatic populations (patients without a history of stroke or transient ischemic attack 
[TIA]).4 For example, the US Preventive Services Task Force (USPSTF) has recommended 
against carotid screening in adult patients without a history of stroke or TIA in both its 2007 
and updated 2014 guidance.5 Other national guidelines favor imaging for some limited 
indications in patients with asymptomatic carotid disease (eg, those with established 
stenosis, carotid bruit, or multiple vascular risk factors) although these recommendations are 
based on expert opinion rather than robust evidence.4,6
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More recently, carotid imaging in asymptomatic populations has been identified by different 
physician specialty organizations as a low-value test and has appeared on several top 5 lists 
in the national “Choosing Wisely” campaign.7 The American Academy of Family 
Physicians,8 for example, has stated, “don’t screen for carotid artery stenosis in 
asymptomatic adults.” The American Academy of Neurology9 has stated, “don’t perform 
imaging of the carotid arteries for simple syncope without other neurologic symptoms,” and 
the Society of Thoracic Surgeons10 has stated, “don’t initiate routine evaluation of carotid 
artery disease prior to cardiac surgery in the absence of symptoms or other high-risk 
criteria.”
Once imaging occurs in an asymptomatic patient, revascularization can be offered to patients 
with carotid stenosis based on current guidelines for primary prevention of stroke.3 
Embedded in these recommendations is an understanding derived from randomized clinical 
trials that patients undergoing revascularization are expected to live for at least 5 years so 
that the short-term risks such as stroke, myocardial infarction, and death posed by the 
procedure are offset by the long-term benefits of stroke risk reduction.3,11 Although the 
evidence in support of efficacy of carotid revascularization to reduce recurrent 
cerebrovascular events among patients with symptomatic carotid disease is strong, the 
majority of revascularization procedures are performed in patients with asymptomatic 
carotid artery disease, in whom the evidence for clinical benefit is more modest and long-
term outcomes are of paramount importance.3,12,13 Therefore, ensuring that patients selected 
for revascularization will live long enough to benefit is critical, and improving patient 
selection for carotid imaging will ultimately improve the selection of revascularization 
recipients.
The long-term health consequences of low-value imaging have not been commonly studied, 
and the risks and benefits of diagnostic imaging are not always clear to patients and 
clinicians.14 To better understand why asymptomatic patients receive carotid artery imaging, 
we examined the indications provided by physicians for carotid ultrasounds in a national 
cohort of patients who received carotid intervention for asymptomatic stenosis in the 
Veterans Health Administration (VHA). Because guidelines recommend that patients who 
receive revascularization have a 5-year life expectancy, we also examined long-term survival 
of these patients after the intervention.
Methods
Sample and Data Sources
This study was approved by the University of California, San Francisco, Committee on 
Human Research. Informed consent was waived because this was a retrospective cohort 
study with no human subject contact and minimal privacy risks. Using national VHA data, 
we identified (N = 4127) patients 65 years and older undergoing carotid endarterectomy 
(CEA) and carotid stenting (CAS) for asymptomatic carotid stenosis between 2005 and 
2009. We defined asymptomatic patients as patients who did not have evidence of any type 
of stroke or TIA in the 6 months prior to receipt of first carotid imaging. To identify 
asymptomatic patients, we used a previously developed high-sensitivity algorithm based on 
International Classification of Diseases, Ninth Revision, codes to exclude patients with 
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stroke (including retinal artery occlusion) and TIA using administrative data.15 We then 
reviewed each patient’s medical record and further excluded any patient with any history of 
stroke and TIA documented in the medical record. We examined the indication for the first 
carotid image each patient received in this period before revascularization. We intentionally 
looked for the first image in this period to reduce the number of nonspecific indications 
provided such as “follow-up.” We limited the sample to carotid ultrasounds rather than all 
imaging because other imaging modalities (eg, computed tomographic angiogram or 
magnetic resonance angiogram) may also be ordered to evaluate other vascular disease and 
carotid findings may be incidental, whereas carotid ultrasound is used primarily to identify 
carotid stenosis. We used national Veterans Affairs (VA) Corporate Data Warehouse and VA 
Medical SAS administrative databases to obtain data on age, sex, comorbidities, and CEA or 
CAS procedures.16 Medical record abstraction was used to confirm that CEA or CAS was 
performed after the first carotid image was obtained and to obtain additional data on 
comorbidities and indications listed by physicians for carotid imaging. Long-term survival 
of the cohort of patients who underwent CEA and CAS was extracted from the VA vital 
status file.16
Identification of Indication for Imaging
All indications for the initial carotid ultrasound were identified by 4 trained abstractors 
(A.W., A.A., R.A., S.S.). The abstractors were trained to review both the carotid report for 
indications listed by providers and the referring providers’ note. Each carotid ultrasound 
could have multiple indications. If the abstractors could not identify an indication based on 
these 2 sources of information or were unsure of the indication, 1 of 3 clinicians (S.K. 
[internist], E.M.C. [neurologist], A.N. [ophthalmologist]) reviewed the medical record and 
assigned an indication. If no indication was identified, then it was classified as unknown and 
the patient was excluded from the sample. If the indication was deemed to be unrelated to 
the carotid artery (eg, evaluation of a neck mass), the image was excluded from the sample. 
The κ for agreement in indications from the medical record for 2 reviewers for 2 separate 
samples of 20 carotid images was very good and ranged from 0.71 to 0.88.
Expert Panel Review of Indications
Expert review of indication was necessary because guideline recommendations on screening 
in asymptomatic populations are limited and conflicting. Table 1 lists all the indications for 
which at least 1 national guideline has issued recommendations. For example, some but not 
all guidelines recommend screening for patients with carotid bruits.4 Given the limited 
guidance available, we convened a multidisciplinary panel of practicing clinicians and stroke 
researchers including 3 internists (S.K., E.A.H., D.M.B.), 2 vascular neurologists (E.M.C., 
L.S.W.), 1 vascular surgeon (J. J.), and 2 ophthalmologists (S.R., A.N.) to review and rate 
the indications through a consensus process. Prior to the first meeting, each panel member 
received a list of indications to be rated. Panel members were instructed to rate each 
indication as appropriate, uncertain, or inappropriate based on a balance of risk and benefit 
of imaging. The ratings were compiled and discussed among panel participants through 2 
conference calls with 1 caveat: the ocular indications were discussed and rated separately by 
the ophthalmologists because many of the indications were based on eye examination 
findings not commonly encountered by other clinicians. Each indication was then discussed 
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by the group and a final rating was assigned on the basis of consensus. The indication was 
rated as uncertain if all raters deemed it uncertain or if consensus on appropriateness was not 
reached. We considered panel members as having agreement on ratings if all panel members 
agreed and disagreement if 1 or more panel members disagreed. Overall, there was 
unanimity on 86.0% of the indications and disagreement on 14.0% of the indications. 
Among the uncertain indications, 50.0% were uncertain based on consensus and 50.0% were 
rated uncertain because of disagreement among the panel members.
Analysis
First, we compared the indications abstracted from the medical record to currently available 
national guidelines to determine how well guidelines cover current practice. Second, we 
compared the indications abstracted from the medical records to the quality assessments 
made by the expert panel. For this analysis, the sample was restricted to the 4063 patients 
whose carotid ultrasound had at least 1 indication listed. If the ultrasound had multiple 
indications, the rating of the test was assigned on the basis of the most appropriate 
indication(s). We calculated percentages of carotid ultrasounds rated appropriate, uncertain, 
or inappropriate. Finally, we also compared 5-year overall survival in patients receiving 
carotid imaging and subsequent medical record–confirmed revascularization among the 3 
appropriateness categories using a log-rank test. Analyses were conducted using SAS, 
version 9.4 (SAS Institute), and Stata, version 12.1.
Results
Patient Characteristics
A total of 4127 patients were in the cohort; 64 patients had no indications provided by 
clinicians, leaving a final sample of 4063 patients (Table 2). The mean (SD) age of this 
cohort was 73.6 (5.9) years; 4014 (98.8%) were male. Comorbidities were common and 
included hypertension (3583 [88.2%]), diabetes mellitus (1607 [39.6%]), and atrial 
fibrillation (442 [10.9%]). The majority of patients received CEA (3373 [83.0%]), while 684 
(16.8%) received CAS, and 6 patients (0.1%) did not have a medical record–confirmed 
revascularization within 5 years after first carotid image.
Frequency and Type of Indications
Overall, there were 5226 indications for 4063 carotid ultrasounds in 4063 patients. 
Approximately 3062 (75.4%) carotid ultrasounds had a single indication while the 
remaining (n = 1001) had multiple indications. Fifty-seven unique indications were 
identified. Among these 57 indications, 32 (56%) were listed 10 or more times and 11 (19%) 
were listed only once. Table 3 provides the entire list of indications grouped by clinical 
themes identified. Overall, there were 6 main clinical themes for ordering carotid images in 
asymptomatic populations that emerged: (1) vascular indications, (2) near-syncope/syncope 
indications, (3) neuropsychiatric indications, (4) ear-related indications, (5) ocular 
indications, and (6) imaging as part of a preoperative evaluation. There were also some 
isolated indications presented in the “other” category that were uncommon (<1% of all 
indications) and could not be clinically grouped. The most common indication listed was 
carotid bruit, which accounted for approximately one-third of all indications (1578 [30.2%] 
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of 5226 indications). Follow-up for carotid disease (stenosis/history of carotid disease) in a 
patient who had previously documented carotid stenosis was the second most common 
indication (1087 [20.8%] of 5226 indications). Carotid bruit and follow-up for carotid 
disease accounted for half (2677 [51.2%] of 5226 indications) of all indications. Multiple 
vascular risk factors were the next most common indication listed. Overall, currently 
available national guidelines shown in Table 1 covered 3593 (68.7%) of the indications 
extracted from this national cohort. The most common areas not covered by guidelines 
included syncope, dizziness/vertigo, remote history of stroke or TIA, and preoperative 
evaluation.
Appropriateness of Carotid Imaging
Each indication was rated using the expert panel’s assessment. The majority of images (3421 
[84.2%]) had a single indication, while the remaining images had between 2 and 4 
indications. A total of 398 (9.8%) images had multiple indications with different levels of 
appropriateness. We assigned each image the most appropriate quality assessment. Some 
carotid ultrasounds had multiple indications with the same quality assessments (eg, 2 
indications that were both appropriate). Rates of appropriate, uncertain, and inappropriate 
imaging were 5.4% (227 indications), 83.4% (3387 indications), and 11.3% (458 
indications), respectively (Table 4). Whereas most of the appropriate indications assigned to 
images were related to ocular disease (164 [72.2%] of 227), the most common appropriate 
indication listed was follow-up within 2 years of carotid intervention. Carotid bruit and 
follow-up for established carotid disease were the most prevalent uncertain indications. 
Among the inappropriate indications, dizziness/vertigo, syncope, and blurred/change in 
vision were the most common (Table 3).
Long-term Survival
Among the 4063 patients in the final sample, 3373 (83.0%) received a CEA. Overall, 663 
procedures were performed in patients 80 years and older. Postintervention overall survival 
in this cohort was 71.4% at 5 years. Rates of survival by age group 65 to 74, 75 to 84, and 85 
years and older were 75.3% (1857 patients), 66.5% (979 patients), and 58.9% (73 patients), 
respectively (P < .001). Rates of survival among patients who received carotid imaging on 
the basis of appropriate, uncertain, and inappropriate indications were not significantly 
different (P = .07) and were 66.4%, 72.1%, and 68.8%, respectively.
Discussion
Most carotid imaging tests that resulted in patients with asymptomatic carotid disease 
undergoing revascularization were performed for indications in which the benefits of 
imaging are uncertain, and 1 in 9 tests were performed for inappropriate indications. We 
found that approximately one-third of indications listed by clinicians are not addressed by 
current national guidelines. We also found that many patients do not live long enough to 
benefit from revascularization.
There is a tension between appropriate screening and appropriate revascularization that 
necessitates further comment. It is possible that a patient would be screened on the basis of 
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an indication that would appear clinically inappropriate for imaging but lead to an otherwise 
appropriate revascularization procedure if severe stenosis was identified. This clinical 
dilemma is the result of the chosen point of reference. From an individual perspective, it 
may be beneficial to have screening that is not guideline based if that screening 
demonstrates a true positive abnormality that is amenable to an effective evidence-based 
intervention. From a societal perspective, screening all patients (including a patient who 
benefited) may not be beneficial (and thus not recommended) if the false-positive rate of the 
screening test is high or the evidence for intervention is weak. This tension between the 
individual perspective (which often does not include consideration of the harms of false-
positive test results) and the societal perspective is at the root of many of the current national 
debates on screening.
In the case of carotid disease, the tension between the individual and population perspective 
is further exacerbated by the fact that different societies have different recommendations 
based on how they define an “asymptomatic” individual.4,5 A patient with vascular disease 
may have asymptomatic carotid disease (ie, no history of stroke or TIA), but by virtue of the 
presence of systemic atherosclerosis, the American Heart Association considers it 
reasonable to screen such patients, whereas the USPSTF does not.
Other areas in which national recommendations differ include further assessment of a 
carotid bruit. In our study, greater than half of all imaging was performed to evaluate for 
carotid bruit and monitor the progression of carotid stenosis, indications that our panel rated 
as of uncertain value because of a lack of evidence in the area. For example, a patient with a 
carotid bruit who is of advanced age and has multiple comorbidities may have little clinical 
benefit from imaging. Such a patient may not live long enough to benefit from intervention. 
Another area in which improved guidance is necessary relates to the duration of follow-up 
imaging for patients with established carotid stenosis. The USPSTF has an overall 
recommendation against any screening in asymptomatic carotid populations, whereas the 
guidelines issued by the American Heart Association in conjunction with other specialty 
societies recommend screening and follow-up for carotid disease in patients with carotid 
bruit and also patients with greater than 50% stenosis.4 Revisiting the evidence base and 
clarifying, expanding, and harmonizing the guidelines for imaging in asymptomatic 
populations may be warranted to reduce potentially unnecessary testing.
The 2 most recent major randomized clinical trials of intervention in asymptomatic patients 
showed that given the procedural risks inherent in CEA and CAS procedures, patients must 
live 5 years to realize a net benefit from revascularization.3,17,18 Roughly one-quarter of the 
patients in our cohort who received intervention did not survive 5 years. This was more than 
double the death rate observed in the most recent trial.17,19 The fact that long-term survival 
was similar for patients who received imaging for indications deemed appropriate or 
uncertain vs inappropriate imaging deserves some comment. Revascularization once carotid 
stenosis is identified may occur without full consideration of a patient’s life expectancy. 
Although patient reassurance, clinician uncertainty, and other reasons might underlie test 
ordering regardless of patient eligibility, these findings could suggest that guideline 
development and decision support for carotid imaging ordering in an asymptomatic patient 
should more fully address eligibility for intervention at the time of initial test ordering.
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Our results also suggest that reducing inappropriate carotid imaging may stem a “pipeline” 
of low-value care because many patients who were subsequently revascularized received 
initial imaging for reasons considered inappropriate by our expert panel. Reducing low-
value carotid imaging can also reduce low-value carotid intervention in patients who will not 
live long enough to benefit. Given that carotid imaging is a fairly commonly ordered test, 
targeting carotid imaging using decision support tools to reduce inappropriate use may be a 
good approach to improve the value of health care without compromising quality. Currently 
there is no guidance on ordering carotid ultrasound in the VHA or in most clinical settings. 
Our study demonstrates that developing such decision support is needed.
The sample chosen for this study has both strengths and limitations. On the one hand, this 
cohort focuses on asymptomatic patients who underwent revascularization and does not 
represent all patients who receive carotid imaging. The distribution of indications may be 
different in a population that did not receive intervention. On the other hand, our cohort is an 
important sample to examine because it provides an assessment of the primary reason for 
screening for carotid stenosis among patients who ultimately received intervention. The 
long-term consequence of this pipeline of low-value care is more apparent. Another 
important limitation to consider is the generalizability of the sample. The indications 
extracted were for carotid ultrasounds ordered by physicians practicing in the VHA, a 
national setting with an electronic health record and electronic ordering system. Our results 
may not represent the scope of indications for which physicians order carotid imaging in 
different settings. However, most VHA hospitals have academic affiliations and many 
clinicians practice in multiple settings; therefore, it is likely that our results are 
representative of academic settings with electronic imaging ordering. Another limitation is 
that our cohort was almost entirely male; however, there is no reason to believe that 
indications listed by physicians for imaging would vary by sex. In addition, appropriateness 
assessment by the expert panel was by full consensus and any disagreement resulted in a 
quality assessment of “uncertain.” Our conservative approach with a requirement of 100% 
agreement among panel members on indications resulted in more quality assessments being 
assigned an “uncertain” rating than an “inappropriate” rating. However, a slight shift in the 
quality assessments from uncertain to inappropriate would not materially affect our 
conclusions. Finally, the indications extracted were for the period of 2005 to 2009; it is 
possible that reasons for ordering carotid images have evolved. However, national guidelines 
currently still conflict.4,5
Conclusions
The majority of patients who undergo carotid revascularization for asymptomatic carotid 
disease received a diagnosis on the basis of results of tests ordered for uncertain or 
inappropriate reasons. Consideration should be given to improving the evidence base around 
carotid testing, especially around monitoring stenosis over long periods and evaluating 
carotid bruits. The ongoing National Institutes of Health–sponsored Carotid 
Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial 
(CREST-2) should clarify the value of revascularization in asymptomatic populations.20 
Finally, clarifying and harmonizing current guidelines and the development of evidence-
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based decision support tools to support appropriate patient selection for carotid imaging in 
practice can reduce the use of low-value imaging and improve long-term patient outcomes.
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Key Points
Question
Why do asymptomatic patients who undergo revascularization receive initial carotid 
imaging?
Findings
In this study of 4127 patients 65 years and older who received carotid revascularization, 
the most common indications provided by physicians for the initial carotid ultrasound 
were carotid bruit and follow-up for carotid disease.
Meaning
Consideration should be given to improving the evidence base around carotid imaging.
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Table 1
Current National Guideline Recommendations on Carotid Imaging in Patients Without a History of Stroke or 
Transient Ischemic Attack (TIA)
Guideline USPSTF5 ASA/AHA4 AIUM6
Screening for asymptomatic carotid artery stenosis in asymptomatic 
adult (ie, someone without a history of TIA or stroke)
Not recommended … …
Routine screening of patients who have no clinical manifestations of 
or risk factors for atherosclerosis
Not recommended No benefit …
Asymptomatic carotid bruit Not recommended Recommendation in favor of 
procedure being useful based on 
diverging expert opinion, case 
studies, or standard of care
Indicated
Follow-up of established carotid stenosis >50% … Recommendation in favor of 
procedure being useful based on 
diverging expert opinion, case 
studies, or standard of care
…
May be considered in asymptomatic patients with symptomatic 
peripheral arterial disease, coronary artery disease, or atherosclerotic 
aortic aneurysm
… Recommendation’s usefulness/
efficacy less well established based 
on diverging expert opinion, case 
studies, or standard of care
…
Might be considered to detect carotid stenosis in asymptomatic 
patients without clinical evidence of atherosclerosis who have 2 or 
more of the following risk factors: hypertension, hyperlipidemia, 
tobacco smoking, family history in a first-degree relative of 
atherosclerosis manifested before age 60 y, or a family history of 
ischemic stroke
… Recommendation’s usefulness/
efficacy less well established based 
on diverging expert opinion, case 
studies, or standard of care
…
Not recommended for routine evaluation of patients with 
neurological or psychiatric disorders unrelated to focal cerebral 
ischemia, such as brain tumors, familial or degenerative cerebral or 
motor neuron disorders, infectious and inflammatory conditions 
affecting the brain, psychiatric disorders, or epilepsy
… No benefit …
Noninvasive imaging of the extracranial carotid arteries is 
reasonable 1 mo, 6 mo, and annually after revascularization to assess 
patency and exclude the development of new or contralateral 
lesions. Once stability has been established over an extended period, 
surveillance at longer intervals may be appropriate. Termination of 
surveillance is reasonable when the patient is no longer a candidate 
for intervention
… Recommendation in favor of 
procedure being useful based on 
diverging expert opinion, case 
studies, or standard of care
Indicated
Carotid duplex ultrasound screening is reasonable before elective 
coronary artery bypass graft surgery in patients older than 65 y and 
in those with left main coronary stenosis, peripheral arterial disease, 
a history of cigarette smoking, a history of stroke or TIA, or carotid 
bruit
… Recommendation in favor of 
procedure being useful based on 
diverging expert opinion, case 
studies, or standard of care
Indicated
Annual noninvasive imaging of the carotid arteries is reasonable 
initially for patients with fibromuscular dysplasia to detect changes 
in the extent or severity of disease, although the effect on outcomes 
is unclear
… Recommendation in favor of 
procedure being useful based on 
diverging expert opinion, case 
studies, or standard of care
…
Abbreviations: AHA, American Heart Association; AIUM, American Institute of Ultrasound Medicine; ASA, American Stroke Association; 
ellipses, no recommendation; USPSTF, US Preventative Services Task Force.
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Table 2
Characteristics of Patients Who Received a Carotid Ultrasound Between 2005 and 2009
Characteristic No. (%) (N = 4063)
Age, y
 65 to 74 2467 (60.7)
 75 to 84 1472 (36.2)
 ≥85   124 (3.1)
Male sex 4014 (98.8)
Comorbidity
 Hypertension 3583 (88.2)
 Hyperlipidemia 3167 (77.9)
 Diabetes mellitus 1607 (39.6)
 Atrial fibrillation   442 (10.9)
 Coronary artery disease 2019 (49.7)
 Peripheral vascular disease 1107 (27.2)
 Congestive heart failure   288 (7.1)
 Chronic obstructive pulmonary disease   798 (19.6)
Procedurea
 Carotid endarterectomy 3373 (83.0)
 Carotid artery stenting   684 (16.8)
a
Medical record review revealed that 6 patients did not receive subsequent intervention.
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Table 4
Expert Panel Rating and Frequency of Indications Per Ultrasound (4774 Indications for 4063 Images)
Patients, No. (%)
Appropriate Indicationsa (n 
= 227) Uncertain Indicationsa (n = 4028) Inappropriate Indicationsa (n = 519)
218 (5.4) 3387 (83.4) 458 (11.3)
Follow-up after CEA/CAS <2 
y, n = 63
Hollenhorst plaque, plaque in 
eye, n = 59
Ocular ischemic syndrome, n 
= 38
Multiple unilateral peripheral 
retinal hemorrhages, n = 36
Eye findings suggestive of 
ocular ischemic syndrome (eg, 
asymmetrical intraocular 
pressure), n = 1
Asymmetrical retinopathy, n = 
30
Carotid bruit, n = 1572
Follow-up for stenosis/history carotid disease, n = 
1073
Hypertension with 1 other vascular risk factor, n = 
500
History of stroke/transient ischemic attack >6 mo, n 
= 194
Follow-up after CEA/CAS (>2 y), n = 172
Preoperative evaluation, n = 145
Old stroke/silent stroke found on neuroimaging, n = 
93
CABG workup, n = 92
Carotid calcification or finding on x-ray or other 
image, n = 79
Suspected carotid disease/rule out carotid disease, n 
= 41
Smoking history with other risk factor, n = 35
Pulsation in ears, n = 14
Neck pain, n = 9
Decreased carotid pulse, n = 5
Cardiac murmur radiating to neck, n = 2
No palpable carotid pulse, n = 2
Dizziness/vertigo, n = 209
Syncope, n = 100
Blurred vision/change in vision, n = 70
Single peripheral retinal hemorrhage, n = 19
Memory loss or dementia, n = 13
Lightheadedness, n = 12
Fall without focal weakness, n = 9
Headache, n = 9
Optic nerve ischemia, n = 8
Branch retinal vein occlusion, n = 7
Generalized weakness, n = 7
Orthostatic hypotension, n = 7
Tilting/change in gait (without focal weakness), n = 7
Tingling of limb without focal weakness, n = 6
Balance problems without focal weakness, n = 5
Seizures, n = 5
Tremor, n = 4
Anterior ischemic optic neuropathy, n = 3
Diplopia, n = 3
Mental status change, n = 2
Nonfocal peripheral neuropathy, n = 2
Tinnitus, n = 2
Cotton wool spot, n = 1
Cystoid macular edema, n = 1
Dyspnea, n = 1
Family history of cerebrovascular accident, n = 1
Jaw pain, n = 1
Occasional dark spot in visual field, n = 1
Optic nerve changes, n = 1
Sequential disk swelling, n = 1
Staggering (without focal weakness), n = 1
Tingling with elevation of head, n = 1
Abbreviations: CABG, coronary artery bypass graft; CAS, carotid stenting; CEA, carotid endarterectomy.
a
If an image had multiple indications, the indication that was most appropriate was listed in Table 3; therefore, there are fewer indications than 
were listed in Table 2. Patients could have multiple appropriate indications, multiple uncertain indications, and multiple inappropriate indications.
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